BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37506341)

  • 1. Prevalence and significance of DDX41 gene variants in the general population.
    Cheloor Kovilakam S; Gu M; Dunn WG; Marando L; Barcena C; Nik-Zainal S; Mohorianu I; Kar SP; Fabre MA; Quiros PM; Vassiliou GS
    Blood; 2023 Oct; 142(14):1185-1192. PubMed ID: 37506341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
    Makishima H; Saiki R; Nannya Y; Korotev S; Gurnari C; Takeda J; Momozawa Y; Best S; Krishnamurthy P; Yoshizato T; Atsuta Y; Shiozawa Y; Iijima-Yamashita Y; Yoshida K; Shiraishi Y; Nagata Y; Kakiuchi N; Onizuka M; Chiba K; Tanaka H; Kon A; Ochi Y; Nakagawa MM; Okuda R; Mori T; Yoda A; Itonaga H; Miyazaki Y; Sanada M; Ishikawa T; Chiba S; Tsurumi H; Kasahara S; Müller-Tidow C; Takaori-Kondo A; Ohyashiki K; Kiguchi T; Matsuda F; Jansen JH; Polprasert C; Blombery P; Kamatani Y; Miyano S; Malcovati L; Haferlach T; Kubo M; Cazzola M; Kulasekararaj AG; Godley LA; Maciejewski JP; Ogawa S
    Blood; 2023 Feb; 141(5):534-549. PubMed ID: 36322930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline DDX41 mutations define a significant entity within adult MDS/AML patients.
    Sébert M; Passet M; Raimbault A; Rahmé R; Raffoux E; Sicre de Fontbrune F; Cerrano M; Quentin S; Vasquez N; Da Costa M; Boissel N; Dombret H; Peffault de Latour R; Socié G; Itzykson R; Fenaux P; Soulier J; Adès L; Clappier E
    Blood; 2019 Oct; 134(17):1441-1444. PubMed ID: 31484648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.
    Maierhofer A; Mehta N; Chisholm RA; Hutter S; Baer C; Nadarajah N; Pohlkamp C; Thompson ER; James PA; Kern W; Haferlach C; Meggendorfer M; Haferlach T; Blombery P
    Blood Adv; 2023 Dec; 7(23):7346-7357. PubMed ID: 37874914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasms.
    Li P; Brown S; Williams M; White T; Xie W; Cui W; Peker D; Lei L; Kunder CA; Wang HY; Murray SS; Vagher J; Kovacsovics T; Patel JL
    Blood; 2022 Aug; 140(7):716-755. PubMed ID: 35671390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms.
    Badar T; Chlon T
    Curr Hematol Malig Rep; 2022 Oct; 17(5):113-120. PubMed ID: 35781188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel DDX41 variants in Thai patients with myeloid neoplasms.
    Polprasert C; Takeda J; Niparuck P; Rattanathammethee T; Pirunsarn A; Suksusut A; Kobbuaklee S; Wudhikarn K; Lawasut P; Kongkiatkamon S; Chuncharunee S; Songserm K; Phowthongkum P; Bunworasate U; Nannya Y; Yoshida K; Makishima H; Ogawa S; Rojnuckarin P
    Int J Hematol; 2020 Feb; 111(2):241-246. PubMed ID: 31713024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
    Lewinsohn M; Brown AL; Weinel LM; Phung C; Rafidi G; Lee MK; Schreiber AW; Feng J; Babic M; Chong CE; Lee Y; Yong A; Suthers GK; Poplawski N; Altree M; Phillips K; Jaensch L; Fine M; D'Andrea RJ; Lewis ID; Medeiros BC; Pollyea DA; King MC; Walsh T; Keel S; Shimamura A; Godley LA; Hahn CN; Churpek JE; Scott HS
    Blood; 2016 Feb; 127(8):1017-23. PubMed ID: 26712909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDX41-related myeloid neoplasia.
    Maciejewski JP; Padgett RA; Brown AL; Müller-Tidow C
    Semin Hematol; 2017 Apr; 54(2):94-97. PubMed ID: 28637623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasms.
    Alkhateeb HB; Nanaa A; Viswanatha D; Foran JM; Badar T; Sproat L; He R; Nguyen P; Jevremovic D; Salama ME; Greipp P; Gangat N; Tefferi A; Litzow MR; Mangaonkar AA; Shah MV; Patnaik M; Al-Kali A
    Blood Adv; 2022 Jan; 6(2):528-532. PubMed ID: 34644397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique ethnic features of
    Choi EJ; Cho YU; Hur EH; Jang S; Kim N; Park HS; Lee JH; Lee KH; Kim SH; Hwang SH; Seo EJ; Park CJ; Lee JH
    Haematologica; 2022 Feb; 107(2):510-518. PubMed ID: 33626862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel bi-alleleic DDX41 mutations in B-cell lymphoblastic leukemia: case report.
    Shin WY; Yoon SY; Park R; Kim JA; Song HH; Bang HI; Won JH; Kim J
    BMC Med Genomics; 2022 Mar; 15(1):46. PubMed ID: 35246110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid neoplasms with germline DDX41 mutation.
    Cheah JJC; Hahn CN; Hiwase DK; Scott HS; Brown AL
    Int J Hematol; 2017 Aug; 106(2):163-174. PubMed ID: 28547672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia.
    Li R; Sobreira N; Witmer PD; Pratz KW; Braunstein EM
    Haematologica; 2016 Jun; 101(6):e228-31. PubMed ID: 26944477
    [No Abstract]   [Full Text] [Related]  

  • 16. AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome.
    Li P; White T; Xie W; Cui W; Peker D; Zeng G; Wang HY; Vagher J; Brown S; Williams M; Kovacsovics T; Patel JL
    Leukemia; 2022 Mar; 36(3):664-674. PubMed ID: 34671111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDX41: the poster child for familial MDS/AML grows up.
    Truong P; Pimanda JE
    Blood; 2023 Feb; 141(5):447-449. PubMed ID: 36729548
    [No Abstract]   [Full Text] [Related]  

  • 18. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
    Churpek JE; Pyrtel K; Kanchi KL; Shao J; Koboldt D; Miller CA; Shen D; Fulton R; O'Laughlin M; Fronick C; Pusic I; Uy GL; Braunstein EM; Levis M; Ross J; Elliott K; Heath S; Jiang A; Westervelt P; DiPersio JF; Link DC; Walter MJ; Welch J; Wilson R; Ley TJ; Godley LA; Graubert TA
    Blood; 2015 Nov; 126(22):2484-90. PubMed ID: 26492932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX41: exploring the roles of a versatile helicase.
    Winstone L; Jung Y; Wu Y
    Biochem Soc Trans; 2024 Feb; 52(1):395-405. PubMed ID: 38348889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
    Homan CC; Drazer MW; Yu K; Lawrence DM; Feng J; Arriola-Martinez L; Pozsgai MJ; McNeely KE; Ha T; Venugopal P; Arts P; King-Smith SL; Cheah J; Armstrong M; Wang P; Bödör C; Cantor AB; Cazzola M; Degelman E; DiNardo CD; Duployez N; Favier R; Fröhling S; Rio-Machin A; Klco JM; Krämer A; Kurokawa M; Lee J; Malcovati L; Morgan NV; Natsoulis G; Owen C; Patel KP; Preudhomme C; Raslova H; Rienhoff H; Ripperger T; Schulte R; Tawana K; Velloso E; Yan B; Kim E; Sood R; Hsu AP; Holland SM; Phillips K; Poplawski NK; Babic M; Wei AH; Forsyth C; Mar Fan H; Lewis ID; Cooney J; Susman R; Fox LC; Blombery P; Singhal D; Hiwase D; Phipson B; Schreiber AW; Hahn CN; Scott HS; Liu P; Godley LA; Brown AL;
    Blood Adv; 2023 Oct; 7(20):6092-6107. PubMed ID: 37406166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.